
BTSG Stock Forecast & Price Target
BTSG Analyst Ratings
Bulls say
BrightSpring Health is delivering impressive financial results, with a significant beat in both EBITDA and revenue in 1Q26. The company's strong performance in both Pharmacy Solutions and Provider Services segments highlights its capabilities and potential for growth in the home and community-based healthcare services market. With a diverse range of services and a strong balance sheet, BrightSpring is well-positioned to capture a significant share of the growing demand for home healthcare services.
Bears say
BrightSpring Health is a mature company, which has recently raised its guidance for 2026; however, the forecasted core EBITDA growth seems conservative compared to its strong first quarter results. The Pharmacy Solutions segment continues to grow and generate high margins, but the decline in Home and Community revenue is concerning. The drag from the IRA may impact overall revenue and EBITDA in 2026, but the company is well-equipped to overcome this challenge through its core business. The company's strong balance sheet and low leverage add to its stability and potential for future growth.
This aggregate rating is based on analysts' research of BrightSpring Health Services Inc and is not a guaranteed prediction by Public.com or investment advice.
BTSG Analyst Forecast & Price Prediction
Start investing in BTSG
Order type
Buy in
Order amount
Est. shares
0 shares